Selected article for: "cardiac dysfunction and long term"

Author: Pérez-Bermejo, Juan A.; Kang, Serah; Rockwood, Sarah J.; Simoneau, Camille R.; Joy, David A.; Ramadoss, Gokul N.; Silva, Ana C.; Flanigan, Will R.; Li, Huihui; Nakamura, Ken; Whitman, Jeffrey D.; Ott, Melanie; Conklin, Bruce R.; McDevitt, Todd C.
Title: SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients
  • Cord-id: pi9ndj9p
  • Document date: 2020_9_12
  • ID: pi9ndj9p
    Snippet: Although COVID-19 causes cardiac dysfunction in up to 25% of patients, its pathogenesis remains unclear. Exposure of human iPSC-derived heart cells to SARS-CoV-2 revealed productive infection and robust transcriptomic and morphological signatures of damage, particularly in cardiomyocytes. Transcriptomic disruption of structural proteins corroborated adverse morphologic features, which included a distinct pattern of myofibrillar fragmentation and numerous iPSC-cardiomyocytes lacking nuclear DNA.
    Document: Although COVID-19 causes cardiac dysfunction in up to 25% of patients, its pathogenesis remains unclear. Exposure of human iPSC-derived heart cells to SARS-CoV-2 revealed productive infection and robust transcriptomic and morphological signatures of damage, particularly in cardiomyocytes. Transcriptomic disruption of structural proteins corroborated adverse morphologic features, which included a distinct pattern of myofibrillar fragmentation and numerous iPSC-cardiomyocytes lacking nuclear DNA. Human autopsy specimens from COVID-19 patients displayed similar sarcomeric disruption, as well as cardiomyocytes without DNA staining. These striking cytopathic features provide new insights into SARS-CoV-2 induced cardiac damage, offer a platform for discovery of potential therapeutics, and raise serious concerns about the long-term consequences of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1